EODData

MEMBERSHIP REGISTER LOG IN

OTCBB, QBIO: Q Biomed Inc

25 Nov 2025
LAST:

0.0001

CHANGE:
 0.00		OPEN:
0.0001		HIGH:
0.0001		ASK:
0.0000		VOLUME:
8.4K
CHG(%):
0.00		PREV:
0.0001		LOW:
0.0001		BID:
0.0000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
25 Nov 250.00010.00010.00010.00018.4K
12 Nov 250.00010.00010.00010.000130.6K

PROFILE

Name:Q Biomed Inc
About:Q BioMed Inc., a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride Sr-89 and Metastron, a radiopharmaceutical therapeutic for the treatment of metastatic bone cancer pain. It is also developing Man-01, that is used for the treatment of primary open angle glaucoma; QBM-001 for rare pediatric non-verbal autism spectrum disorder; and Uttroside-B, a novel chemotherapeutic for liver cancer. Q BioMed Inc. has a partnership with Mannin Research Inc. for the development of therapeutic drugs to treat acute respiratory distress syndrome, glaucoma, kidney diseases, and others. The company was formerly known as ISMO Tech Solutions, Inc. and changed its name to Q BioMed Inc. in July 2015. Q BioMed Inc. was incorporated in 2013 and is based in New York, New York.
Sector:Healthcare
Industry:Biotechnology
Address:366 Madison Avenue, New York, NY, United States, 10017
Website:https://www.qbiomed.com
CUSIP:74736N105
CIK:0001596062
ISIN:US74736N1054
FIGI:BBG0063BQSD4

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:0.000.0%
MA10:0.000.0%
MA20:0.000.0%
MA50:0.000.0%
MA100:0.000.0%
ATR:0.00 
Week High:0.000.0%
Week Low:0.000.0%
Month High:0.0325,000.0%
Month Low:0.00

RECENT SPLITS

Date Ratio
07 Aug 20155-2